A Critical Review of Nirgundi (Vitex Negundo linn.)- In Classical Texts

Nirgundi is a large aromatic shrub or small tree grows upto 4.5m height common throughout the country. Nirgundi is clinically used in many diseases by all most all traditional system of medicine because of its diverse medicinal properties. The drug was mentioned during Vedic period and was used in various diseases in Ayurveda since Samhita kala. Nirgundi is having Katu Tikta Kashaya Rasa, Laghu Ruksha Guna, Ushna Veerya and Vata Kaphahara property. Nirgundi is having Deepani, Kusghtaghna, Krimighna, Medhya, Shothahara, Shulahara Karma, and mainly used in Vatavyadhi, Karna Roga, Krimi Kushta, Rajayakshma, Gulma Chikitsa. For the fulfillment of treatment in Ayurveda the knowledge of Dravya including its Rasapanchaka, synonym are very important, without the knowledge of which the treatment is impossible. Nirgundi is one such drug having diversified properties and the opinion of different authors regarding the use of the drug is very necessary in treating diseases starting from common fever to anxiety. Thus the synonyms and their interpretation, Vernacular names, Rasapanchaka, Rogaghnata and Karma, Yoga of Nirgundi in Brihatrayi and various Nighantus Dhanwantri Nighantu, Shodhala Nighantu, Madanpala Nighantu, Kaiyadeva Nighantu, Raja Nighantu and Bhavprakasha Nighantu, has been described and this paper presented a classical review of Vitex negundo Linn. mentioned in Ayurveda.

Comparison of efficacy and safety of Vitex negundo 600 mg (Ascof® Forte) capsules with Vitex negundo 600 mg (Ascof® Forte) tablets in the treatment of acute uncomplicated cough among Filipino adults in Cavite

Objectives@#Vitex negundo is an endemic shrub in the Philippines which has been clinically tested for the symptomatic treatment of cough in syrup and tablet formats. However, the effectiveness and safety of the capsule have not been formally documented in a clinical trial setting. Therefore, in compliance with the Philippine FDA directive, this study compared the efficacy and safety of the capsule and tablet formats after three days of treatment among Filipinos with acute uncomplicated cough. @*Methods@#This is a Phase 3b randomized, open-label, parallel-group non-inferiority study with 335 subjects using improvement based on Global Rating of Change Scale scores as primary efficacy endpoint and several secondary endpoints. Descriptive and inferential analyses were performed. The Farrington-Manning Method of Z-test with -10% non-inferiority margin was used for the primary outcome. Appropriate inferential tests were used for the secondary outcomes. @*Results@#Of 335 enrolled subjects, 170 were randomized to the capsule group and 165 to the tablet group with comparable baseline characteristics. The proportion of success based on the Global Rating of Change Scale rated by patients was 95.71% and 91.19% for the capsule and tablet groups, respectively. Based on doctors’ ratings, they were 96.93% and 94.34%, respectively. In addition, the Farrington-Manning Method of Z-test revealed the capsule was not inferior to the tablet based on patients’ and doctors’ ratings (90% Confidence Intervals: -0.0086 to 0.0988 and -0.0228 to 0.0747, respectively). The intention-to-treat analysis also showed non-inferiority, indicating robust results. Significant and similar improvements in cough severity and quality of life were observed in both groups based on Cough Severity Diary scores and Leicester Cough Questionnaire for acute cough, respectively. There were also improvements in the Forced Expiratory Volume at 1 second [FEV1] (capsule group) and Peak Expiratory Flow Rate [PEFR] (both groups), but these were not clinically significant. The safety profiles were also comparable (p= 0.4437) with 1.23% and 2.52% incidence of adverse events, respectively, all of which were mild and assessed as not related to the drug. @*Conclusion@#In terms of efficacy, Ascof® Forte capsule was non-inferior to Ascof® Forte tablet in treating acute uncomplicated cough among Filipinos based on Global Rating of Change Scale scores as rated by patients and doctors. Both treatments showed significant and similar improvements in cough severity and quality of life. They were also comparable in safety with few adverse events in both groups, all mild and assessed unrelated to drug intake.

Phytochemical investigation on Vitex negundo leaves and their anti-inflammatory and analgesic activities

Abstract The phytochemical investigation on Vitex negundo leaves has led to the isolation of one new iridoid glucoside (8α-hydroxy-4-carboxyl-5ßH-9ßH-iridoid-1α-O-(6'-O-(6,7-dihydrofoliamenthonyl)-ß-ᴅ-glucopyranoside, 3), together with three known compounds, namely agnuside (1), 6'-O-E-caffeoylmussaenosidic acid (2), and 3,5-dicaffeoylquinic acid (4). The HPLC analytical study was also performed to quantify the content of agnuside (1) in dried leaves. The results indicated the very high content of 1 (3.04 ± 0.02%). The method was also validated by various parameters, including linearity (R2= 0.9999), precision (intra-day RSD ≤ 2.50%, inter-day RSD= 0.76%), and accuracy (recovery rates 96.58-101.86%). The animal testing data showed that the extract did not reduce pain at the doses of 9.6 and 28.8 g /kg (leaf weight/body weight) in the hot plates and pain measuring models but showed the pain reduction in the acetic acid-induced pain model. The extract at the dose of 5.6 g/kg (leaf weight/body weight) also had effects on the acute inflammation in the carrageenin-induced edema model. The extract at the dose 9.6 and 28.8 g/kg (leaf weight/body weight) also showed significant chronic anti-inflammation, comparable to methylprednisolone at the dose 10 mg/kg on the mouse peritoneal

Effect of methonolic extract of Vitex negundo on haloperidol induced catalepsy in albino mice

Background: Plants are being used in traditional medicine since history of mankind. The knowledge of these medicinal plants has accrued in the course of many centuries leading to medicinal systems in India such as Ayurveda, Unani and Siddha. Objective: In the present study, we evaluated the anticataleptic efficacy of Vitex negundo, a polyherbal formulation in haloperidol induced catalepsy in mice.Methods: Five groups (n=6) of male albino mice were used in the study. Catalepsy was induced by i.p. administration of haloperidol (1 mg/kg). The degree of catalepsy (cataleptic score) was measured as the time the animal maintained an imposed posture. We compared the anticataleptic efficacy of Vitex negundo (50, 100, 200 mg/kg) with standard received Pheniramine maleate 10 mg/kg, i.p.Results: In vehicle treated animals, haloperidol (1 mg/kg. i.p.) produced the maximum catalepsy at 180 min (46.78�78 min). Standard treated as Pheniramine maleate 10 mg/kg, i.p. shows maximum at 120 min. 19.24�32. Test herb, i.p. Methanolic extract of Vitex negundo (50, 100, 200 mg/kg, i.p.) significantly potentiated haloperidol induced catalepsy at each time interval, in a dose dependent manner. At dose 50, 100 and 200mg/kg, extract of Vitex negundo (Linn.) roots showed maximum cataleptic score 12.34�78, 14.43�43 and 15.43�67 min, respectively at 120 minutes in haloperidol treated animals.Conclusions: The present study indicates that the methanolic extract of Vitex negundo reduces haloperidol-induced catalepsy in mice.

Pharmacological Properties Of Nirgundi: A Review

Owing to wide range of medicinal properties, Nirgundi is very useful herb. It is used for its medicinal values for thousands of years by the people all over the globe. The folklore healers use the plant for various ailments. As per Ayurvedic system of medicine, its Rasa is Katu, Tikta and Kashaya and it pacifies Vata and Shleshma. Its property is Laghu and Veerya is Sheetoshna and is used in the treatment of various disorders like Pleeha rog, Gulma, Krimi, Kushtha, Vrana, Visha and Aruchi. Available ancient and modern contemporary literature has been studied thoroughly while preparing this article so as to put all the available knowledge about the herb at one place. Various properties possessed by the plant have been evaluated in different studies, and results or observations of few of such prominent studies have been presented here to enrich the knowledge. Review of the available literature showed that it possesses various pharmacological activities cardiotonic, anti-inflammatory, analgesic, anti-histaminic, anti-cancerous, anxiolytic, anti-asthmatic, hepatoprotective etc. All these properties have been authenticated by various experimental and clinical studies. So keeping in view the huge potential of the plant, further research is suggested to extract maximum benefits for the benefit of the society.

A novel polyherbal formulation containing thymoquinone attenuates carbon tetrachloride-induced hepatorenal injury in a rat model

Objective: To evaluate a novel polyherbal formulation (BSVT) containing the standardized extracts from the leaves of Boerhavia diffusa, Solidago virgaurea, Vitex negundo, and thymoquinone in CCl

A novel polyherbal formulation containing thymoquinone attenuates carbon tetrachloride-induced hepatorenal injury in a rat model

Objective: To evaluate a novel polyherbal formulation (BSVT) containing the standardized extracts from the leaves of Boerhavia diffusa, Solidago virgaurea, Vitex negundo, and thymoquinone in CCl4 induced hepatorenal toxicity in rats. Methods: A total of 36 rats were divided into six groups including normal control, CCl4 (2 mL/kg, i.p.), CCl4 (2 mL/kg, i.p.) + Cystone? (750 mg/kg p.o.), CCl4 (2 mL/kg, i.p.) + BSVT (25 mg/kg, p.o.), CCl4 (2 mL/kg, i.p.) + BSVT (50 mg/kg, p.o.), and CCl4 (2 mL/kg, i.p.) + BSVT (100 mg/kg, p.o.). All treatments were given for four weeks. Serum levels of aspartate transaminase, alanine transaminase, alkaline phosphatase, cholesterol, total protein, serum urea, blood urea nitrogen and creatinine were assessed. Superoxide dismutase, malondialdehyde, and glutathione peroxidase were evaluated in tissue homogenate. The histopathological study of liver and kidney tissues was also done. Results: Aspartate transaminase, alanine transaminase, alkaline phosphatase, cholesterol, serum urea, blood urea nitrogen and creatinine were significantly elevated (P<0.001) while total protein was considerably reduced in the CCl4 group as compared to the normal control (P<0.001), which indicated hepatorenal toxicity. In addition, superoxide dismutase and glutathione peroxidase activities were significantly decreased (P<0.001) while malondialdehyde levels were increased markedly (P<0.001). Treatment with BSVT formulation recovered these parameters towards a normal level in a dose-dependent manner. Conclusions: BSVT formulation ameliorates the hepatorenal toxicity in a dose-dependent manner. Furthermore, clinical studies are required to confirm its efficacy.

Effect of ethanolic extract of Vitex negundo leaves on experimentally induced inflammatory bowel disease in albino rats

Background: Ulcerative colitis (UC) and Crohn’s disease (CD) are collectively known as inflammatory bowel disease (IBD). Pathophysiology of IBD is not known with certainty. Immunological processes and reactive oxygen species (ROS) have been proposed to contribute considerably to development of tissue injury. Some of the intestinal and/or colonic injury and dysfunction observed in IBD is due to elaboration of these reactive species. Commonly used drugs, in particular sulfasalazine and its active moiety 5-aminosalicylic acid, are potent ROS scavengers. The present study was carried out to evaluate the effect of ethanolic extract of Vitex negundo (EEVN) leaves on experimentally induced inflammatory bowel disease in albino rats.Methods: The rats were divided into four groups of six animals each. Group A and group B received gum acacia per orally, group C received EEVN in dose of 500 mg/kg/day per orally, and group D received 5-amino salicylic acid (5-ASA) in the dose of 100 mg/kg/day per orally. All the animals were pre-treated with respective drugs (volume of drugs was kept constant at 10 ml/kg) for five days, along with the normal diet. On fifth day animals were kept fasting for 12 hours (overnight) and IBD was induced next morning in Groups B, C and D by administration of one ml of 4% acetic acid solution transrectally (TR). Group A (normal control) received 0.9% normal saline transrectally (TR) instead.Results: The results have been shown that EEVN has significant activity against experimentally induced IBD when compared to the experimental control, with near normalization of colon architecture both macroscopically as well as microscopically. Tissue oxidative stress was reduced with significant improvement in tissue levels of superoxide dismutase (SOD) and catalase (CAT). Also, significant improvement in levels of myeloperoxidase (MPO) was observed.Conclusions: It is concluded that ethanolic extract of leaves of Vitex negundo has got potent activity against experimentally induced IBD due to its anti-inflammatory and anti-oxidant properties.

Larvicidal activity of essential oil from Vitex negundo and Vitex trifolia on dengue vector mosquito Aedes aegypti

Abstract INTRODUCTION: The ability of Vitex trifolia and Vitex negundo essential oils to kill Aedes aegypti and Culex quinquefasciatus larvae was evaluated. METHODS: The larvae were treated with their respective essential oils at 50-125 ppm concentration. RESULTS: LC50 and LC90 for V. trifolia against Ae. aegypti and C. quinquefasciatus, and those for V. negundo against Ae. aegypti were 57.7+0.4, 77.9+0.9 ppm and 55.17+3.14, 78.28+2.23 ppm, and 50.86+0.9, 73.12+1.3 ppm, respectively. Eucalyptol and caryophyllene were the major components in Vitex trifolia and Vitex negundo essential oil, respectively. CONCLUSIONS: This study revealed potential larvicidal properties of essential oil from V. trifolia.

A systematic review on Vitex negundo (NIRPROMP formulations) for the treatment of acute cough of mild to moderate severity in pediatric patients

Objective@#The aim of this systematic review was to evaluate the efficacy and safety of Vitex negundo (lagundi) for the treatment of acute cough of mild to moderate severity among pediatric patients.@*Methods@#A systematic review of randomized controlled trials (RCTs) comparing lagundi to placebo for acute cough of mild to moderate severity in children and adolescents aged two to twenty one years in ambulatory settings was performed. Authors of unpublished clinical trials with existing patent numbers were contacted and permission was obtained to access and include their studies in this review. @*Results@#Seven studies were included, with a total of 308 participants. Lagundi increased the peak exploratory flow rate (PEFR) at the end of therapy compared with placebo but this was not statistically significant (p=0.36). The increase in PEFR was consistent with the results of the mechanistic isolated tissue studies that showed bronchodilating effect of lagundi. Studies using lagundi syrup showed decrease in the frequency of cough by 44–71%.@*Conclusion@#Lagundi therapy in acute cough of mild to moderate severity among pediatric patients has a bronchodilating effect and decreases the frequency and duration of coughing, with no serious adverse effects.

Phenols from Vitex negundo / 中成药

AIM To study the phenols from Vitex negundo Linn..METHODS The ethyl acetate fraction of 70％ ethanol extract from V.negundo was isolated and purified by silica,Sephadex LH-20 and ODS column,then the structures of obtained compounds were identified by spectral data.RESULTS Seven compounds were isolated and identified as luteolin-4'-O-β-D-glucopyranoside (1),isoorientin 6-O-caffeate (2),3,4,5-tricaffeoyl quinic acid (3),(+)-pinoresinol-4-O-β-D-glucoside (4),methyl isoferuloyl-7-(3,4-dihydroxyphenyl) lactate (5),benzyl 7-O-β-D-glucoside (6) and oresbiusin A (7).CONCLUSION All the compounds are isolated from this plant for the first time,and compounds 1,3,5-7 are first isolated from genus Vitex.

Qualitative and quantitative identification of Vitex negundo var. cannabifolia fruits and Vitex negundo fruits / 中草药

Objective To provide experimental basis for the identification of Vitex negundo var. cannabifolia fruits and V. negundo fruits by comparative study. Methods The original plant identification, morphological identification, microscopic identification, TLC and HPLC identification were adopted to distinguish the two kinds of materials. Results It is difficult to tell the difference of these two medicinal fruits in term of original plant identification and morphological identification to their similarity, while microscopic identification, TLC and HPLC identification revealed that the characteristics of sclereid could be used to distinguish these two fruits. Conclusion Microscopic identification on the sclereid characteristics of fruits powder, combined with TLC and HPLC identification can be the feasible method that used to distinguish V. negundo fruits and V. negundo var. cannabifolia fruits.

Characterization of metabolites in rats after gavage of two lignans from fruits of Vitex negundo var. cannabifolia by UFLC-IT-TOF-MS / 中草药

Objective: To investigate in vivo metabolic profiles of two lignans, 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3- hydroxymethyl-7-methoxy-3,4-dihydro-2-naphthaldehyde (VB-1) and vitedoin A (VB-2) in the rats. Methods: A UFLC-IT- TOF-MS method was applied to characterize the prototypes and metabolites of VB-1 and VB-2 in rat feces, urine, bile, and plasma after oral administration. Results: Eleven metabolites of the two parent compounds were detected and two prototypes were identified unambiguously by comparing with references. Analysis of metabolites revealed that glucuronidation, sulfation, and hydroxylation were major biotransformation pathways of two lignans. Conclusion: In this study, under the analysis of metabolites of two lignans, its in vivo metabolic process is basically clarified. The results could be helpful for the further pharmacokinetics and pharmacological evaluations of VB-1 and VB-2.

Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model

ABSTRACT The objective of the study is to formulate and evaluate a topical herbal gel containing Cardiospermum halicacabum and Vitex negundo leaf extracts for their anti-arthritic activity in rats. Twelve herbal gel formulations were prepared using 1.5% of gelling agents carbopol 934 (F1-F6) and carbopol 940 (F6-F12) and they were evaluated for physical appearance, net content, viscosity, extrudability, pH, spreadability, in vitro diffusion profile and primary skin irritation tests. The stability study for the topical herbal gel formulation was done as per ICH guidelines and anti-arthritic activity was evaluated by Freund's Complete Adjuvant (FCA) induced arthritis method. Assessment of body weight, paw volume, hematological and biochemical parameters, histopathological examination and In vitro determination of serum biomarkers were also carried out. Formulated gels were homogenous, stable and complied with the guidelines. Among the formulations, F4 showed better release (98.4 %) characteristics than other formulations. No erythema or edema was observed in the skin irritation test confirming the gel was non-toxic and safe. Topical application of the herbal gel F4 containing carbopol 934 displayed significant (p < 0.001) anti-arthritic activity compared to diseased rats. Reduction in paw volume, no agglutination in C - reactive protein and rheumatic factor, reduction in TNF level, regaining of normal hematological, and biochemical parameters, reduction in spleen and thymus weight and histopathological examination supported the anti-arthritic activity of the gel formulation.

Chemical constituents from the fruits of Vitex negundo var. cannabifolia and their biological activities in vitro / 中国中药杂志

Chemical constituents from the fruits of Vitex negundo var. cannabifolia and their nitric oxide (NO) inhibitory and cytotoxic activities were investigated. The compounds were isolated and purified by various column chromatography, and their structures were identified by physiochemical properties and spectroscopic data. Thirteen lignans and six phenolic compounds were isolated from the CH2Cl2 extract of the fruits of V. negundo var. cannabifolia, respectively. Their structures were elucidated as 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-3,4-dihydro-2-naphthaldehyde (1), vitedoin A (2), vitexdoin F (3), detetrahydroconidendrin (4), vitexdoin E (5), 4-oxosesamin (6), L-sesamin (7), (+)-beechenol (8), ligballinol (9), 2-(4-hydroxyphenyl)-6-(3-methoxy-4-hydroxyphenyl)-3,7-dioxabicyclo[3.3.0]octane (10), (-)-pinoresinol (11), balanophonin (12), thero-guaiacylglycerol-β-coniferyl aldehyde ether (13), trans-p-coumaryl aldehyde (14), coniferyl aldehyde (15), 5,7-dihydroxychromone (16), trans-3,5-dimethoxy-4-hydroxy-cinnamic aldehyde (17), frambinone (18), and alternariol 4-methyl ether (19). Compounds 8-10,14,18,19 were firstly isolated from Verbenaceae family, compound 13 was obtained from Vitex species, and 6,7,12,15-17 from V. negundo var. cannabifolia for the first time, respectively. The isolated compounds were evaluated for their anti-inflammatory and cytotoxic effects in vitro. Eight compounds (3,5,7,10,11,14,15,17) showed inhibition against NO production in LPS-stimulated RAW 267.4 cells (IC₅₀ in the range of 7.8-81.1 μmol•L⁻¹) and four compounds (1-4) showed cytotoxicity on HepG-2 cells (IC₅₀ in the range of 5.2-24.2 μmol•L⁻¹).

Chemical constituents from Vitex negundo var. heterophylla / 中草药

Objective: To study the chemical constituents in the twigs of Vitex negundo var. heterophylla. Methods: A variety of silica gel column chromatography, Sephadex LH-20 gel column chromatography, and HPLC methods were used for the separation and purification of chemical composition. Their structures were identified on the basis of physicochemical property and spectral data. Results: Eight compounds were obtained and identified as apigenin-6-C-β-D-glucopyranosyl 8-C-α-L-arabinopyranoside (1), isoorientin (2), luteolin-6-C-α-L-arabinopyranosyl-8-C-β-D-glucopyranoside (3), luteolin-6,8-di-C-α-L-arabinopyranoside (4), apigenin-6-α-L- arabinopyranosyl-8-C-β-D-glucopyranoside (5), luteolin-6-C-α-L-arabinopyranosyl 8-C-β-L-arabinopyranoside (6), luteolin-6-C-β-L- arabinopyranosyl-8-C-β-D-glucopyranoside (7), and luteolin-7-O-β-D-glucopyranoside (8). Conclusion: Compounds 1 and 3-7 are first isolated from the plants of Vitex Linn.

A new flavonoid glycoside from leaves of Vitex negundo var. cannabifolia / 中草药

Objective: To investigate the flavonoid glycosides from the leaves of Vitex negundo var. cannabifolia. Methods: Column chromatography including silica gel, Sephadex LH-20, and ODS was used to separate and purify the chemical constituents, and their structures were elucidated by physicochemical properties, MS, and NMR spectroscopic data. Results: Seven flavonoid glycosides were obtained from the ethyl acetate layer of 95% EtOH extract of the leaves of V. negundo var. cannabifolia, and identified as luteolin-4'-O-(6″-O-p-hydroxybenzoyl)-β-D-glucoside (1), luteolin-7-O-(6″-O-p-hydroxybenzoyl)-β-D-glucoside (2), luteolin-6-C-(6″-O-trans-caffeoyl)-β-D-glucoside (3), luteolin-6-C-(2″-O-trans-caffeoyl)-β-D-glucoside (4), perfoliatumin A (5), isovitexin (6), and luteolin-7-O-β-D-glucoside (7). Conclusion: Compound 1 is a new compound named cannabifolin G; Compounds 2-4 and 7 are obtained from this plant for the first time; Compound 5 is firstly isolated from the plants in Vitex L.

Antifungal Properties and Chemical Analysis of Essential Oil from Vitex negundo Seeds.

Aims: To investigate the constituents and antimicrobial activity of essential oil from Vitex negundo seeds. Study Design: The essential oil of Vitex negundo seeds was prepared by hydrodistillation. GC/MS technique was used to determine the volatile constituents in the oil. A total of 13 isolates of bacteria and fungi were employed to evaluate the antimicrobial activity of the oil. Place and Duration of Study: Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, between April 2010 and September 2010. Methodology: Essential oil from Vitex negundo seeds were obtained by hydrodistillation, with constituents analyzed by GC-MS. Antimicrobial activity of the oil was evaluated against both Gram-positive and Gram-negative bacteria and fungi. Results: A total of forty-two components, representing 91.36% of the oil, were identified. n-Hexadecanoic acid (17.68%), eudesm-4(14)-en-11-ol (12.39%) and caryophyllene oxide (10.79%) were found to be the major constituents. The essential oil exhibited significant antifungal activity against Candida albicans at MIC 4.0 μg/ml. Conclusion: The essential oil of Vitex negundo seeds showed potential antifungal activity and can be of potential use in pharmaceutical fields.

Comparative assessment of extraction methods and quantitative estimation of luteolin in the leaves of Vitex negundo Linn. by HPLC

Objective: To find out the ideal organic solvent and extraction technique for the isolation of luteolin from the leaves of Vitex negundo Linn. (V. negundo) by quantitative estimation of luteolin through high performance liquid chromatography (HPLC) method. Methods: The leaves of V. negundo were identified by a botanist, cleaned, dried under shade and powdered. Maceration, reflux, Soxhlet and ultrasound assisted extraction techniques were used for the extraction of luteolin from the leaves by using four different solvents of varying polarity such as methanol, ethanol, chloroform, and dichloromethane. A simple HPLC method was used to determine the quantity of luteolin in each sample extract. Results: The calibration plot of standard luteolin showed a linear relationship in the concentration range of 100-500 μg/mL with a correlation coefficient, r

A new triterpenoid glycoside from Vitex negundo / 中国天然药物

AIM@#To investigate the chemical constituents of Vitex negundo.@*METHOD@#Compounds were isolated by different chromatographic methods and their structures were elucidated on the basis of NMR spectroscopy.@*RESULTS@#Four compounds were isolated and identified as 2α, 3α, 24-trihydroxyurs-12, 20(30)-dien-28-oic acid-28-O-β-D-glucopyranosyl ester (1), corosolic acid (2), vulgarsaponin A (3) and 2α, 3α, 24-trihydroxyurs-12-en-28-oic acid-28-O-β-Dglucopyranosyl ester (4), respectively.@*CONCLUSION@#Compound 1 is a new triterpenoid glycoside.